# ACS Dobfar S.p.A. – FDA Inspection, Oct 23, 2009

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/3ac8e004-c46b-4ac9-b510-f1f1d97721b7
Source feed: FDA_Inspections

> FDA inspection 630765 of ACS Dobfar S.p.A., October 23, 2009. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 630765
- Company Name: ACS Dobfar S.p.A.
- Inspection Date: 2009-10-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1203381 - 2022-04-08
- FDA Inspection 1123735 - 2018-04-13
- [FDA Inspection 1019162 - 2017-07-21](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/584779c1-9978-4f42-ac8d-32841973f716)
- [FDA Inspection 955350 - 2016-01-19](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/26802884-ae0f-4afa-94bd-6b134f9c3430)
- FDA Inspection 881223 - 2014-05-23

Company: https://www.keypedia.com/companies/acs-dobfar-spa/8d824293-8979-42d8-822b-2373460bbf88

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c